ATM and neoplasm: Gene alterations in BRCA1, BRCA2, and ATM were detected in 2.0, 10.7, and 8.8%, respectively, of cfDNA samples and in 1.6, 8.2, and 5.8%, respectively, of tumour tissue samples [67].